AptarGroup, Inc. (NYSE:ATR) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• AptarGroup has a “Moderate Buy” consensus rating from eight analysts, with five buys and three holds; the average 12-month price target is $172.80.
• The company beat quarterly earnings expectations, reporting adjusted EPS of $1.42 versus the $1.35 consensus and revenue of $1.03 billion, up 6.3% year over year. Management issued third-quarter EPS guidance of $1.45–$1.53.
• AptarGroup declared a quarterly dividend of $0.48 per share, equivalent to $1.92 annually and a 1.5% yield; institutional investors own 88.52% of the company’s stock.

AptarGroup, Inc. (NYSE:ATR - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $172.80.

Several analysts recently commented on ATR shares. Bank of America upgraded AptarGroup from a "neutral" rating to a "buy" rating and set a $173.00 price target for the company in a research report on Tuesday, July 14th. Weiss Ratings restated a "hold (c)" rating on shares of AptarGroup in a report on Wednesday, June 24th. Wells Fargo & Company lifted their target price on shares of AptarGroup from $145.00 to $155.00 and gave the stock an "overweight" rating in a research note on Monday, August 3rd. Finally, Raymond James Financial reaffirmed an "outperform" rating and set a $160.00 target price on shares of AptarGroup in a report on Wednesday, July 15th.

AptarGroup Trading Up 1.6%

Shares of AptarGroup stock opened at $125.37 on Wednesday. The company has a current ratio of 1.61, a quick ratio of 1.10 and a debt-to-equity ratio of 0.42. AptarGroup has a twelve month low of $103.23 and a twelve month high of $146.91. The firm has a market capitalization of $7.97 billion, a PE ratio of 22.67, a P/E/G ratio of 3.15 and a beta of 0.38. The firm's 50-day moving average price is $130.91 and its 200 day moving average price is $125.90.

AptarGroup (NYSE:ATR - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The industrial products company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.35 by $0.07. AptarGroup had a return on equity of 13.31% and a net margin of 9.22%.The company had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same period in the previous year, the business earned $1.66 EPS. AptarGroup's quarterly revenue was up 6.3% on a year-over-year basis. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS. On average, sell-side analysts predict that AptarGroup will post 5.48 EPS for the current fiscal year.

AptarGroup Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 20th. Investors of record on Thursday, July 30th were given a dividend of $0.48 per share. The ex-dividend date was Thursday, July 30th. This represents a $1.92 dividend on an annualized basis and a yield of 1.5%. AptarGroup's payout ratio is presently 34.72%.

Insider Buying and Selling at AptarGroup

In other AptarGroup news, insider Shiela Vinczeller sold 765 shares of the firm's stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $130.37, for a total value of $99,733.05. Following the transaction, the insider directly owned 26,313 shares of the company's stock, valued at $3,430,425.81. This trade represents a 2.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Stephan B. Tanda sold 9,838 shares of the company's stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.16, for a total value of $1,339,542.08. Following the completion of the sale, the chief executive officer owned 238,729 shares of the company's stock, valued at $32,505,340.64. This trade represents a 3.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 23,197 shares of company stock valued at $3,134,828. Insiders own 0.73% of the company's stock.

Institutional Trading of AptarGroup

Several large investors have recently added to or reduced their stakes in ATR. BlackRock Inc. acquired a new position in shares of AptarGroup during the 2nd quarter valued at about $768,464,000. Victory Capital Management Inc. raised its stake in AptarGroup by 4.0% during the fourth quarter. Victory Capital Management Inc. now owns 2,291,454 shares of the industrial products company's stock worth $279,466,000 after purchasing an additional 88,717 shares during the period. Geode Capital Management LLC boosted its holdings in AptarGroup by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 1,618,896 shares of the industrial products company's stock valued at $197,473,000 after purchasing an additional 15,197 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in AptarGroup by 15.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,504,473 shares of the industrial products company's stock valued at $189,581,000 after purchasing an additional 203,672 shares during the last quarter. Finally, Fiduciary Management Inc. WI boosted its holdings in AptarGroup by 9.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 1,247,557 shares of the industrial products company's stock valued at $152,152,000 after purchasing an additional 104,667 shares during the last quarter. 88.52% of the stock is currently owned by hedge funds and other institutional investors.

About AptarGroup

AptarGroup, Inc is a global supplier of dispensing, packaging and drug-delivery solutions. The company develops and manufactures pumps, valves, aerosol systems, closures, dispensing devices and other components used to package and deliver products in the pharmaceutical, beauty, personal care, food and beverage markets.

Its pharmaceutical offerings include nasal, respiratory, ophthalmic and dermal drug-delivery systems, as well as components and technologies designed to support the administration of prescription and consumer healthcare products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.